Peter Kvacskay
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 23, 2024
bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease.Peter Kvacskay, Ute Hegenbart, Hanns-Martin Lorenz
|Apr 22, 2024
Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission.Manuel Röhrich, Juan J Rosales, Jorge Hoppner
|Mar 09, 2024
CD19.CAR T cells versus obinutuzumab-who will win the race for use in deep B cell depletion therapy in systemic autoimmunity?Peter Kvacskay, Wolfgang Merkt
|Jul 21, 2023
Whole exome sequencing of a German sarcoidosis family with four affected and one spontaneous remission case.Peter Kvacskay, Thomas El Jammal, Hanns-Martin Lorenz
|Apr 19, 2022
Leflunomide in combination with JAK inhibitors in the treatment of rheumatoid arthritis: a case series.Peter Kvacskay, Nobert Blank, Hanns-Martin Lorenz
|Jan 14, 2022
Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series.Peter Kvacskay, Wolfgang Merkt, Janine Günther
Pageof 1
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=75)
